SGDR
PTCT icon

SPX Gestao de Recursos’s PTC Therapeutics PTCT Stock Holding History

SPX Gestao de Recursos’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,000
Closed -$1.13M – 128
2024
Q4 		$1.13M Buy
+25,000
New +$1.07M 0.17% 61

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPX Gestao de Recursos's PTCT Position: Q1 2025 in Review

SPX Gestao de Recursos sold out of PTC Therapeutics (PTCT) in Q1 2025, closing a stake of 25,000 shares — an estimated $1.13M sold.

SPX Gestao de Recursos first reported a position in PTCT in Q4 2024 and held it in 1 quarter. The position peaked at $1.13M in Q4 2024. 260 funds tracked by Wall St. Rank hold PTCT as of Q1 2025.

  • SPX Gestao de Recursos reported no remaining PTC Therapeutics position as of Q1 2025 after selling out during the quarter.
  • SPX Gestao de Recursos sold 25,000 PTC Therapeutics shares in Q1 2025, an estimated $1.13M.
  • SPX Gestao de Recursos first reported a position in PTC Therapeutics in Q4 2024 and held it in 1 quarter.
  • SPX Gestao de Recursos's PTC Therapeutics position peaked at $1.13M in Q4 2024.
  • 260 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2025.

Based on SPX Gestao de Recursos's 13F filing for Q1 2025, filed 14 May 2025.